Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid.

MLA

Beck, Kristen M., et al. “Disease Stabilization with Pembrolizumab for Metastatic Acral Melanoma in the Setting of Autoimmune Bullous Pemphigoid.” Journal for Immunotherapy of Cancer, vol. 4, Apr. 2016, p. 20. EBSCOhost, https://doi.org/10.1186/s40425-016-0123-3.

APA

Beck, K. M., Dong, J., Geskin, L. J., Beltrani, V. P., Phelps, R. G., Carvajal, R. D., Schwartz, G., Saenger, Y. M., & Gartrell, R. D. (2016). Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid. Journal for Immunotherapy of Cancer, 4, 20. https://doi.org/10.1186/s40425-016-0123-3

Chicago

Beck, Kristen M, Joanna Dong, Larisa J Geskin, Vincent P Beltrani, Richard G Phelps, Richard D Carvajal, Gary Schwartz, Yvonne M Saenger, and Robyn D Gartrell. 2016. “Disease Stabilization with Pembrolizumab for Metastatic Acral Melanoma in the Setting of Autoimmune Bullous Pemphigoid.” Journal for Immunotherapy of Cancer 4 (April): 20. doi:10.1186/s40425-016-0123-3.